Results 201 to 210 of about 655,147 (306)

Usefulness of platelet-rich fibrin as a hemostatic agent after dental extractions in patients receiving anticoagulant therapy with factor Xa inhibitors: a case series [PDF]

, 2019
Carlos Fernando Mourão, Richard J. Miron, Rafael Coutinho Mello-Machado, Shahram Ghanaati, Gutemberg Gomes Alves, Mônica Diuana Calasans‐Maia   +5 more
openalex   +1 more source

Comparison of outcomes in patients with intracranial hemorrhage on factor Xa inhibitors versus vitamin K antagonists treated with 4-factor prothrombin complex concentrate

Proceedings, 2018
Sarah Harrison, J. Garrett, Kelsey N Kohman, J. Kline   +3 more
semanticscholar   +1 more source

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers. [PDF]

Front Pharmacol
Lenard A, Hermann SA, Stoll F, Burhenne J, Foerster KI, Czock D, Mikus G, Meid AD, Haefeli WE, Blank A.   +9 more
europepmc   +1 more source

Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord, 2023
Park DY, An S, Arif AW, Sana MK, Vij A.
europepmc   +1 more source

Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage: The prospective observational multicenter ASTRO-DE study

Hans‐Christoph Diener, Nils Kuklik, Anika Hüsing, Angelika Alonso, Darius G. Nabavi, Sven Poli, Maria M. Gabriel, Ilko Maier, Johanna Gräns   +8 more
openalex   +1 more source

Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

, 2003
Wenrong Huang, Penglie Zhang, Jingmei F Zuckett, Lingyan Wang, John Woolfrey, Yonghong Song, Zhaozhong J. Jia, Lane A. Clizbe, Ting Su, Katherine Tran, Brian Huang, Paul Wong, Uma Sinha, Gary Park, Andrea Reed, J Malinowski, Stanley J. Hollenbach, Robert M. Scarborough, Bing‐Yan Zhu   +18 more
openalex   +1 more source

In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra

, 2022
Herm Jan M. Brinkman, Marleen Zuurveld, Joost C.M. Meijers   +2 more
openalex   +1 more source

The Efficacy of Andexanet Alfa for the Reversal of Factor Xa Inhibitors Is Not Influenced by Hemodilution with Different Volume Expanders. [PDF]

J Clin Med
Wienhold J, Rossaint R, Vandeput E, Grottke O.   +3 more
europepmc   +1 more source

Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study. [PDF]

J Clin Med, 2022
Rauch S, Müller HP, Dreyhaupt J, Ludolph AC, Kassubek J, Althaus K.   +5 more
europepmc   +1 more source

Acceleration of recombinant tissue-type plasminogen activator-induced reperfusion and prevention of reocclusion by recombinant antistasin, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosis. [PDF]

, 1992
Michael J. Mellott, Marie A. Holahan, Joseph J. Lynch, G P Vlasuk, Christopher T. Dunwiddie   +4 more
openalex   +1 more source